Does provision of cash incentive to HIV-infected tuberculosis patients improve the treatment success in programme settings? A cohort study from South India

• Published in: Journal of family medicine and primary care Vol. 9; no. 8; pp. 3955 - 3964
• Main Authors: Rohit, Amuje, Kumar, Ajay, Thekkur, Pruthu, Shastri, Suresh, Kumar, Ravi, Nirgude, Abhay, Reddy, Mahendra, Ravichandra, Chinnappareddy, Somashekar, Narasimhaiah, Balu, P
• Format: Journal Article
• Language: English
• Published: India Wolters Kluwer India Pvt. Ltd 01.08.2020; Medknow Publications and Media Pvt. Ltd; Wolters Kluwer - Medknow; Wolters Kluwer Medknow Publications
• Subjects: cash incentives; conditional cash transfer; direct benefit transfer; Drug therapy; HIV; HIV infections; HIV patients; monetary incentives; Neuropeptide Y; operational research; Original; Patient compliance; sort it; Tuberculosis; India; Cash incentives; conditional cash transfer; SORT IT; Direct Benefit Transfer; monetary incentives; Operational Research
• ISSN: 2249-4863; 2278-7135
• DOI: 10.4103/jfmpc.jfmpc_474_20

Background: In April 2018, the Government of India launched 'Nikshay Poshan Yojana' (NPY), a cash assistance scheme (500 Indian rupees [~8 USD] per month) intended to provide nutritional support and improve treatment outcomes among tuberculosis (TB) patients. Objective: To compare the treatment outcomes of HIV-infected TB patients initiated on first-line anti-TB treatment in five selected districts of Karnataka, India before (April-September 2017) and after (April-September 2018) implementation of NPY. Methods: This was a cohort study using secondary data routinely collected by the national TB and HIV programmes. Results: A total of 630 patients were initiated on ATT before NPY and 591 patients after NPY implementation. Of the latter, 464 (78.5%, 95% CI: 75.0%-81.8%) received at least one installment of cash incentive. Among those received, the median (inter-quartile range) duration between treatment initiation and receipt of first installment was 74 days (41-165) and only 16% received within the first month of treatment. In 117 (25.2%) patients, the first installment was received after declaration of their treatment outcome. Treatment success (cured and treatment completed) in 'before NPY' cohort was 69.2% (95% CI: 65.6%-72.8%), while it was 65.0% (95% CI: 61.2%-68.8%) in 'after NPY' cohort. On adjusted analysis using modified Poisson regression we did not find a statistically significant association between NPY and unsuccessful treatment outcomes (adjusted relative risk-1.1, 95% CI: 0.9-1.3). Conclusion: Contrary to our hypothesis and previous evidence from systematic reviews, we did not find an association between NPY and improved treatment outcomes.